Conference Reports for NATAP
The Liver Meeting
Digital Experience
AASLD
November 13 - 16 - 2021
Back
 
INTERFERON DRIVES HEPATITIS C VIRUS SCARRING OF THE EPIGENOME
AND CREATES TARGETABLE VULNERABILITIES FOLLOWING VIRAL CLEARANCE
AASLD 2021 Nov 12-15 Ryan Hlady Mayo Clinic